|
Volumn 17 Suppl 15, Issue , 2011, Pages
|
Optimizing outcomes in patients with cardiovascular disease and chronic kidney disease.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
ANTILIPEMIC AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
CARDIOVASCULAR DISEASE;
CHRONIC KIDNEY FAILURE;
HUMAN;
REVIEW;
UNITED STATES;
ANGIOTENSIN RECEPTOR ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
CARDIOVASCULAR DISEASES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPOLIPIDEMIC AGENTS;
KIDNEY FAILURE, CHRONIC;
UNITED STATES;
|
EID: 84859928743
PISSN: None
EISSN: 19362692
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (0)
|